New approaches to gene therapy and prognostic markers in melanoma
The c-myc proto-oncogene plays a key role in cell proliferation, malignant transformation and apoptosis. Previous work at RAFT demonstrated that c-myc expression levels are an accurate prognostic marker in melanoma. Ribozymes are catalytic RNA molecules that cleave specific mRNA sequences to prevent...
Main Author: | Ramsden, Alex |
---|---|
Published: |
University College London (University of London)
2005
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.419862 |
Similar Items
-
Improving outcome in melanoma by early detection and identification of novel prognostic markers
by: Pacifico, Marc Dominic
Published: (2005) -
Prognostic factors in very thin melanoma
by: Fearfield, Louise Anne
Published: (2003) -
Prognostic assessment of choroidal melanoma based on interphase cytogenetics and pathological features
by: Sandinha, Teresa
Published: (2007) -
Purinergic signalling in malignant melanoma
by: White, Nicholas
Published: (2005) -
Development and validation of novel autophagy biomarkers for malignant melanoma
by: Ellis, Robert Alexander
Published: (2013)